Chemours Q2 Earnings & Revenues Beat Estimates on Higher Volumes

Core Insights - The Chemours Company reported a net loss of $381 million or $2.54 per share for Q2 2025, compared to a net income of $60 million or 39 cents in the same quarter last year [1] - Adjusted earnings were 58 cents per share, exceeding the Zacks Consensus Estimate of 46 cents [1] Financial Performance - Q2 2025 net sales reached $1,615 million, a 4% increase from the previous year, surpassing the Zacks Consensus Estimate of $1,568.3 million [2] - Adjusted EBITDA improved by 22% year-over-year to $253 million, driven by volume growth, pricing, and lower corporate expenses [2] - Cash used by operating activities in the first half of 2025 was $19 million, significantly lower than $910 million in the prior-year period [6] Segment Performance - Titanium Technologies division revenues were $657 million, a 3% decrease year-over-year, but above the estimate of $640.1 million, primarily due to a 4% decrease in price [3] - Thermal & Specialized Solutions segment revenues increased by 15% year-over-year to $597 million, driven by an 11% increase in volume and a 4% increase in price, exceeding the estimate of $582.6 million [4] - Advanced Performance Materials unit revenues were flat at $346 million year-over-year, beating the estimate of $332.9 million, with a 6% decrease in volume offset by a 6% increase in pricing [5] Future Outlook - For Q3 2025, the company expects consolidated net sales to decrease by 4-6% sequentially, with adjusted EBITDA projected between $175 million and $195 million [7] - Full-year 2025 sales are expected to be between $5.9 billion and $6 billion, with adjusted EBITDA between $775 million and $825 million [8] Stock Performance - Chemours shares have declined by 32.1% over the past year, compared to a 23.1% decline in the industry [9]